Colgate-Palmolive
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Colgate-Palmolive's revenues will grow 3.5% and EPS will increase 7.7%.
The average estimate for revenue is $4.32 billion. On the bottom line, the average EPS estimate is $1.40.
Revenue details
Last quarter, Colgate-Palmolive chalked up revenue of $4.33 billion. GAAP reported sales were 1.2% lower than the prior-year quarter's $4.38 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $1.38. GAAP EPS of $1.36 for Q3 were 3.8% higher than the prior-year quarter's $1.31 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 58.4%, 160 basis points better than the prior-year quarter. Operating margin was 23.8%, 90 basis points better than the prior-year quarter. Net margin was 15.1%, 40 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $17.13 billion. The average EPS estimate is $5.35.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,305 members out of 1,355 rating the stock outperform, and 50 members rating it underperform. Among 494 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 484 give Colgate-Palmolive a green thumbs-up, and 10 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Colgate-Palmolive is hold, with an average price target of $108.37.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Colgate-Palmolive. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Colgate-Palmolive to My Watchlist.